H1N1 influenza, also known as swine flu, is an infectious disease caused by the influenza A (H1N1) virus. This virus consists of segmented RNA and is a subtype of influenza A, which, like other types of influenza viruses, causes acute respiratory disease in humans. H1N1 was first identified in pigs but later spread to humans in 2009, causing a pandemic. Symptoms can range from mild respiratory symptoms to severe complications, including pneumonia and acute respiratory distress syndrome. Given the rapid spread of infection and the potential for serious consequences, H1N1 influenza poses a significant public health threat.
History of the disease and interesting historical facts
The first mention of the H1N1 virus as a disease of pigs dates back to the 1930s, when it was identified in pigs in the United States. The virus had an impact on the pig industry, causing epizootics among livestock. However, in 2009, a new wave of interest in H1N1 arose when it mutated and caused a pandemic known as the swine flu pandemic. According to the World Health Organization (WHO), from April 2009 to August 2010, 1.4 million cases were reported worldwide. Interestingly, unlike traditional flu viruses, H1N1 more often affected younger and healthier groups of the population, which distinguished it from the usual seasonal flu, which is more often seen in people over 65 years of age.
Epidemiology
According to the WHO and the Centers for Disease Control and Prevention (CDC), H1N1 has caused significant morbidity and mortality worldwide. About 150,000–575,000 deaths from H1N1 were reported in the first year of the pandemic. In subsequent years, despite the decline in the severity of the epidemic, the H1N1 virus continues to circulate in the population, causing seasonal influenza epidemics, making it relevant in subsequent years. In recent decades, studies have shown that the aging of the population, as well as the emergence of new strains of the virus, contribute to the occurrence of new outbreaks.
Genetic predisposition to this disease
Research suggests that genetics plays a major role in susceptibility to H1N1. In some cases, mutations in certain genes have been identified that may increase the risk of severe disease. Analysis has shown that variations in genes involved in the immune response may influence susceptibility to infections. For example, polymorphisms in interleukins and other cytokines may determine how quickly and effectively the body can fight infections, including H1N1. Research into genetic epidemiology is ongoing, and the findings may help develop more targeted prevention and treatment methods.
Risk factors for the development of this disease
Risk factors for developing H1N1 influenza can be divided into several categories:
- Physical factors: chronic lung diseases such as asthma and COPD; cardiovascular diseases; diabetes; obesity.
- Chemical factors: Exposure to toxic substances such as heavy metals and pesticides can weaken the immune response.
- Other possible factors include smoking, a sedentary lifestyle, lack of flu vaccination, and living conditions that promote the spread of the virus, such as crowded spaces.
The presence of these factors in themselves is not decisive, but their combination significantly increases the risk of infection and the severity of the disease.
Diagnosis of this disease
Diagnosis of H1N1 influenza typically begins with a thorough history and physical examination. Common symptoms reported by patients include:
- High temperature;
- Cough;
- Sore throat;
- Muscle and joint pain;
- Fatigue;
- Headache;
- Difficulty breathing and shortness of breath.
Laboratory tests include polymerase chain reaction (PCR) to detect viral RNA, serologic tests to detect antibodies to the virus, and viral load monitoring. Radiologic tests, such as chest radiography, may be helpful if pneumonia is suspected. Differential diagnosis includes other respiratory infections, including common influenza, COVID-19, and respiratory syncytial virus.
Treatment
General treatment for H1N1 influenza is based on supportive therapy, which includes:
- Ensure adequate fluid intake;
- Rest to speed up recovery;
- Symptomatic treatment to reduce high fever and pain.
Pharmacological treatment may include antiviral drugs such as oseltamivir (Tamiflu) and zanamivir (Relenza), which are most effective when started early. In some cases, hospitalization may be required for more in-depth observation and treatment. Surgery is not usually used in this context, unless severe complications such as pleurisy requiring drainage develop. Other treatments, such as inhaled bronchodilators, may be indicated for acute exacerbations of asthma.
List of medications used to treat this disease
The most common antiviral drugs used to treat H1N1 include:
- Oseltamivir (Tamiflu);
- Zanamivir (Relenza);
- Peramivir (Rapivab);
- Baloxavir (Xofluza).
To treat secondary bacterial infections, antibiotics such as amoxicillin and azithromycin may be prescribed depending on the clinical situation.
Disease monitoring
Monitoring of patients with H1N1 includes regular assessment of symptoms and vital signs. The prognosis is generally good, especially with adequate early treatment, but predisposed patients may develop complications such as viral pneumonia, pleurisy, and acute respiratory distress syndrome.
Age-related features of the disease
H1N1 flu can manifest itself differently depending on the age category of patients:
- Children: Those affected may exhibit classic symptoms such as fever and cough, with an increased risk of dehydration.
- Adults: Usually have a milder illness, but hospitalizations are not uncommon among people with chronic illnesses.
- Older people: The risk of severe disease is significantly increased due to a weakened immune system.
The outcome of the disease largely depends on risk factors, including concomitant diseases and the general health of the patient.
Questions and Answers
- What is the main prevention of H1N1 flu? Vaccination is a key method of prevention, especially for risk groups.
- What are the symptoms of H1N1 flu? Common symptoms include high fever, cough, headache, sore throat and muscle pain.
- Can H1N1 flu be cured with antibiotics? Antibiotics are not effective against viruses, but may be used for secondary bacterial infections.
- How dangerous is H1N1 flu for pregnant women? Pregnant women are at risk and should be especially attentive to symptoms of the disease.
- What is the most effective treatment for H1N1? Antiviral drugs provide the best results when started early.
In conclusion, Dr. Oleg Korzhikov advises the following: "It is important to remember that disease prevention begins with vaccination, especially in high-risk groups. When the first symptoms of flu appear, such as high temperature or cough, you should consult a doctor for timely diagnosis and treatment. Do not ignore your health, especially during the period of viral activity."
